VM — Voyageur Pharmaceuticals Balance Sheet
0.000.00%
- CA$27.65m
- CA$26.74m
Annual balance sheet for Voyageur Pharmaceuticals, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.
2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | 2024 November 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.003 | 0.813 | 0.032 | 0.002 | 0.166 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.013 | 0.042 | 0.024 | 0.036 | 0.052 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.026 | 0.887 | 0.157 | 0.089 | 0.359 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.24 | 1.67 | 1.92 | 2.06 | 2.23 |
| Other Long Term Assets | |||||
| Total Assets | 1.28 | 2.57 | 2.1 | 2.16 | 2.6 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.91 | 0.621 | 0.591 | 0.674 | 2.09 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.969 | 0.661 | 0.631 | 0.728 | 2.15 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.306 | 1.91 | 1.46 | 1.44 | 0.45 |
| Total Liabilities & Shareholders' Equity | 1.28 | 2.57 | 2.1 | 2.16 | 2.6 |
| Total Common Shares Outstanding |